ANI Pharmaceuticals (ANIP) SVP & CFO Stephen Carey Sells Shares

What Happened

• Stephen P. Carey, SVP & Chief Financial Officer of ANI Pharmaceuticals (ANIP), sold 2,850 shares of company stock in an open-market transaction on July 29, 2026. The weighted-average sale price was $81.36 per share, for total proceeds of $231,876. The trade was reported on a Form 4 filed July 30, 2026.

Key Details

• Transaction type: Sale (code S)
• Transaction date: 2026-07-29
• Price: weighted average $81.36; individual trade prices ranged $80.61–$81.88 (multiple trades)
• Shares sold: 2,850; proceeds: $231,876
• Shares owned after transaction: Not disclosed in the information provided in this summary (not included in the supplied filing details)
• Footnotes: Transaction executed under a Rule 10b5-1 trading plan adopted March 6, 2026; price shown is weighted average of multiple trades
• Filing timeliness: Reported the next day (Form 4 filed 2026-07-30), not indicated as late

Context

• This was a routine insider sale under a pre-established 10b5-1 plan. Such plan-based sales are scheduled in advance and do not necessarily indicate a change in the insider’s view of the company. Purchases generally carry more weight for signaling than routine sales.